Supernus Pharmaceuticals
SUPN
#4016
Rank
HK$22.33 B
Marketcap
HK$387.84
Share price
-2.51%
Change (1 day)
52.24%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: HK$22.33 Billion

As of March 2026 Supernus Pharmaceuticals has a market cap of HK$22.33 Billion. This makes Supernus Pharmaceuticals the world's 4016th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$22.33 B-2.93%
2025HK$23.00 B44.35%
2024HK$15.93 B29.08%
2023HK$12.34 B-18.04%
2022HK$15.06 B24.59%
2021HK$12.09 B17.27%
2020HK$10.31 B6.26%
2019HK$9.70 B-28.69%
2018HK$13.60 B-14.73%
2017HK$15.96 B64.54%
2016HK$9.69 B90.02%
2015HK$5.10 B84.51%
2014HK$2.76 B18.35%
2013HK$2.33 B37.37%
2012HK$1.70 B

End of Day market cap according to different sources

On Mar 29th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

HK$22.28 Billion
by Nasdaq info icon info icon
HK$22.33 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.538 T 20,221.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.415 T 6,237.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$6.156 T 27,466.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$936.11 B 4,091.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
HK$11.74 B-47.39%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$179.46 B 703.61%๐Ÿ‡บ๐Ÿ‡ธ USA